# MedRule — Phase 8B.8D: Controlled IPM Batch 3 Implementation Report

**Execution Date:** October 22, 2026  
**Governing Baseline:** Phase 8B.8A Evidence Review (`reports/phase_8b8a_ipm_evidence_review.md`), Phase 8B.8A Batch Plan (`reports/phase_8b8a_ipm_batch_plan.json`), authoritative `2026 Evolent Interventional Pain Management Guidelines.pdf`, and authoritative `EPOS 1755 for Place of Service - Interventional Pain Management 2026_final.pdf`.  
**Scope:** Batch 3 Implementation Only (2 authorized rules).

---

## 1. Executive Summary

Phase 8B.8D implements **Batch 3 only** of the Interventional Pain Management (IPM) domain, transforming two policy stub rules into clinically faithful, source-verified decision tree structures:
1. `RULE-IPM-CGSPINALCORDSTIM-001` — Spinal Cord Stimulation (SCS) Trial, Guideline 1757
2. `RULE-IPM-EPOS1755-001` — IPM Place of Service (POS) Site of Care Exceptions, EPOS 1755

Every clinical threshold, prerequisite, exclusion, psychological evaluation component, MRSA/MSSA decolonization plan timing requirement, and site-of-care clinical exception has been verified directly against the physical pages of the authoritative 2026 Evolent IPM guidelines and EPOS 1755 PDFs.

Crucially, the architecture strictly enforces the **separation between Clinical Necessity and Place of Service (POS)**. Under EPOS 1755, a failure to meet hospital outpatient site-of-care criteria triggers a redirection notice to an ambulatory surgery center or office setting; it does not result in a clinical necessity denial when clinical criteria are met.

Both modified rules remain strictly in `DRAFT` status. The active rule inventory of 128 rules remains exactly intact, with zero approved rules in the governance database, and all seven canonical governance gates intact and blocked.

The full repository regression test suite passed with **100% success (400 passed, 9 subtests passed, 0 failed)**, advancing from 369 passed in Batch 2 with 31 new comprehensive test cases.

---

## 2. Authoritative Policy Sources & Pages Reviewed

| Rule ID | Clinical Guideline | Policy Title | Physical Pages Reviewed | Document Pages | Applicable CPT / HCPCS Codes |
|---|---|---|---|---|---|
| `RULE-IPM-CGSPINALCORDSTIM-001` | Guideline 1757 | Spinal Cord Stimulation (SCS) & DRGS Trial | **78–81** | 1–4 | `63650`, `63685` |
| `RULE-IPM-EPOS1755-001` | EPOS 1755 | Place of Service: Interventional Pain Management | **1–4** | 1–4 | `27096`, `62321`, `62323`, `64490`, `64493`, `64510`, `64520`, `64530`, `64633`, `64635`, `63650`, `63685`, etc. |

---

## 3. Detailed Rule Implementation & Source Citations

### 3.1 RULE-IPM-CGSPINALCORDSTIM-001: Spinal Cord Stimulation (SCS) Trial
- **Guideline:** Evolent CG 1757 (Physical pp. 78–81)
- **Clinical Service:** Trial stimulation of spinal cord or dorsal root ganglion for chronic intractable neuropathic pain.
- **CPT Codes Covered:** `63650` (Percutaneous implantation of neurostimulator electrode array, epidural), `63685` (Pulse generator/receiver insertion/replacement).
- **Implemented Structure:**
  - **Prerequisites (`ALL_OF`):**
    - `COND-IPM-SCS-CHRONIC-PAIN-DURATION`: Intractable pain duration $\ge 6$ months (`pain_duration_months >= 6.0`). Verbatim physical page 78: *"Chronic, intractable neuropathic pain of at least 6 months duration that is unresponsive to other treatment modalities."*
    - `COND-IPM-SCS-CONSERVATIVE-CARE`: Failed $\ge 6$ months conservative therapy within prior 12 months (`conservative_treatment_duration_months >= 6.0` and `conservative_therapy_failed == True`, or documented medical exception). Verbatim physical page 78: *"Failed conservative therapy for a minimum of 6 months in the last 12 months... including active physical therapy, medication management, and interventional procedures unless contraindicated."*
    - `COND-IPM-SCS-PSYCH-EVAL`: Multidisciplinary psychological evaluation within 12 months clearing candidate and documenting all 4 mandatory elements (`psychological_clearance_documented == True` and `psychological_eval_all_elements_present == True`). Verbatim physical page 78: *"A comprehensive multidisciplinary psychological evaluation performed within the preceding 12 months that addresses and confirms: 1) The individual has the cognitive ability to understand and manage the device; 2) Absence of untreated substance abuse/addiction; 3) Absence of untreated psychiatric disorders that would interfere with successful treatment; 4) Realistic expectations of pain relief and treatment goals."*
    - `COND-IPM-SCS-BASELINE-PAIN`: Baseline pain $\ge 6/10$ or functional disability (`pain_intensity_score_numeric >= 6` OR `functional_disability_documented == True`). Verbatim physical page 78: *"Average pain score of ≥ 6 on a scale of 0 to 10 or documented functional disability."*
    - `COND-IPM-SCS-MRSA-SCREENING`: Mandatory MRSA/MSSA decolonization plan timing: patient is either not colonized (`mrsa_mssa_colonization_present == False`) OR colonized with a documented decolonization plan to be performed no earlier than 10 days prior to the planned procedure (`decolonization_plan_documented == True` and `decolonization_timing_days_prior_to_procedure <= 10`). Verbatim physical page 78: *"All patients colonized with methicillin-sensitive or methicillin-resistant Staphylococcus aureus (MRSA or MSSA) must have a decolonization plan to be performed no earlier than 10 days prior to the planned procedure."*
    - `COND-IPM-SCS-NO-CONTRAINDICATIONS`: Absence of clinical contraindications: no active systemic or local infection (`active_infection_present == False`), no untreated addiction (`untreated_substance_addiction == False`), no active untreated psychosis/suicide risk (`untreated_psychiatric_disorder == False`), no cognitive inability (`cognitive_inability_to_manage_device == False`), no uninterrupted anticoagulation contraindication (`uninterrupted_anticoagulation_contraindicated == False`), and not pregnant (`pregnancy_present == False`). Verbatim physical pages 78–79.
  - **Clinical Indication Pathways (`ANY_OF`):**
    - **Pathway 1 (Spinal Cord Stimulation Indications):**
      - Failed Back Surgery Syndrome (FBSS) with persistent radicular symptoms (`failed_back_surgery_syndrome_present == True` and `persistent_radicular_pain_present == True`). Verbatim physical page 78: *"Failed Back Surgery Syndrome (FBSS) with persistent radicular pain."*
      - OR Complex Regional Pain Syndrome (CRPS Type I or Type II) meeting Budapest criteria (`crps_type_i_or_ii_present == True`). Verbatim physical page 78.
      - OR Diabetic Peripheral Neuropathy (DPN) refractory to at least 3 classes of pharmacologic agents (`diabetic_peripheral_neuropathy == True` and `failed_three_drug_classes == True`). Verbatim physical page 78.
      - OR Refractory Angina Pectoris with non-revascularizable coronary artery disease (`refractory_angina_pectoris == True`). Verbatim physical page 78.
    - **Pathway 2 (Dorsal Root Ganglion Stimulation - DRGS Indications):**
      - Severe lower-extremity chronic intractable pain due to CRPS Type I or Type II (`drgs_requested == True`, `crps_type_i_or_ii_present == True`, and `lower_extremity_crps_pain == True`). Verbatim physical page 79: *"Dorsal Root Ganglion Stimulation (DRGS) is medically necessary for the treatment of severe intractable pain of the lower limbs in individuals with Complex Regional Pain Syndrome (CRPS) types I and II."*

---

### 3.2 RULE-IPM-EPOS1755-001: IPM Place of Service (POS) Site of Care Exceptions
- **Guideline:** Evolent EPOS 1755 (Physical pp. 1–4)
- **Clinical Service:** Cross-cutting determination of medically necessary site of care for interventional pain procedures (Outpatient Hospital setting vs. Ambulatory Surgery Center / Office).
- **Engine Classification:** `DecisionTrack.PLACE_OF_SERVICE`.
- **CPT Codes Covered:** Cross-cutting across IPM domain procedures.
- **Implemented Structure:**
  - Evaluates whether the patient meets at least one of 16 recognized clinical high-risk exceptions justifying an Outpatient Hospital setting (`ANY_OF`):
    1. `pediatric_patient_under_18 == True` (Pediatric age $< 18$) (Physical p. 1).
    2. `asa_physical_status_score >= 3` (ASA Physical Status Class III, IV, or V) (Physical p. 1).
    3. `severe_cardiovascular_disease == True` (Unstable angina, MI within 6 months, severe valvular disease, LVEF $< 30\%$, sustained ventricular arrhythmias) (Physical p. 1).
    4. `severe_chronic_pulmonary_disease == True` (Severe COPD/asthma, FEV1 $< 50\%$, home oxygen therapy, pulmonary hypertension) (Physical p. 2).
    5. `severe_obstructive_sleep_apnea == True` (Severe OSA with AHI $\ge 30$ or moderate OSA with cardiopulmonary comorbidity) (Physical p. 2).
    6. `end_stage_renal_disease == True` (ESRD requiring hemodialysis or peritoneal dialysis) (Physical p. 2).
    7. `severe_hepatic_disease == True` (Child-Pugh Class B or C, cirrhosis with portal hypertension or ascites) (Physical p. 2).
    8. `patient_bmi >= 40.0` OR (`patient_bmi >= 35.0` AND `morbid_obesity_with_severe_systemic_disease == True`) (Morbid obesity) (Physical p. 3).
    9. `coagulation_disorder_or_uninterrupted_anticoagulation == True` (Active bleeding diathesis or uninterrupted therapeutic anticoagulation) (Physical p. 3).
    10. `history_malignant_hyperthermia_or_difficult_airway == True` (Documented history of malignant hyperthermia or Mallampati Class IV / severe airway compromise) (Physical p. 3).
    11. `pregnancy_present == True` (Current pregnancy) (Physical p. 3).
    12. `extensive_or_revision_surgery_prolonged_anesthesia == True` (Anticipated operative time $> 2$ hours or significant blood loss) (Physical p. 3).
    13. `brittle_or_poorly_controlled_diabetes == True` (Brittle diabetes with frequent hypoglycemia or HbA1c $\ge 9.0\%$) (Physical p. 3).
    14. `active_uncontrolled_seizure_disorder == True` (Active seizure disorder refractory to medical management) (Physical p. 3).
    15. `acute_functional_decline_or_neuromuscular_disease == True` (Acute functional decline or progressive neuromuscular disease) (Physical p. 4).
    16. `prior_adverse_sedation_reaction_requiring_icu == True` (Prior adverse reaction to anesthesia/sedation requiring emergency resuscitation or ICU admission) (Physical p. 4).
  - **Clinical / POS Separation Behavior:**
    - If a patient meets clinical indications for a procedure (e.g., SCS Trial) but does not meet any of the 16 outpatient hospital criteria in EPOS 1755:
      - `clinical_necessity_outcome`: `CRITERIA_MET`
      - `place_of_service_outcome`: `CRITERIA_NOT_MET`
      - `overall_outcome`: `CRITERIA_NOT_MET`
      - Policy redirection notice: Procedure is clinically indicated; redirect request from Hospital Outpatient Department to an Ambulatory Surgery Center (ASC) or Office setting. Clinical necessity is NOT denied.

---

## 4. Backup Verification & Files Modified

### 4.1 Byte-for-Byte Pre-Implementation Backups
Pre-implementation backups were created in `scratch/phase8b8d_backups/` and verified prior to modifying any files.

| File | Backup Size (bytes) | Backup SHA256 Hash | Post-Implementation Size (bytes) | Post-Implementation SHA256 Hash | Modification Scope |
|---|---|---|---|---|---|
| `draft_rules.json` | 103,384 | `081382df5d0595877eee80df604446461933322d945fe2d9bcab2577f9a59fb8` | 121,006 | `d7c8bbcc251d22c259b4412c95331370bbb8cf90aeb8f4e28c843fae7c4549f3` | Exactly 2 authorized rules (`RULE-IPM-CGSPINALCORDSTIM-001`, `RULE-IPM-EPOS1755-001`) |
| `spinal_cord_stimulation_63650_63685.json` | 3,668 | `056e8b895659d5e4ce602016f9eb02c337284c33c648c9fc73a01959e96fef99` | 17,244 | `d28de1395ecbd4c365225a94baf7592483ab56e1d020ff925e01ff0a4f1862e9` | Updated `RULE-IPM-CGSPINALCORDSTIM-001` to multi-pathway tree; `002` preserved |
| `epos_1755_site_of_care.json` | 3,682 | `892a126311a11c091d3d02b77476713399390cd8b9ec7f041dbf923a8a2f0848` | 8,458 | `fe11b58faa629c9da96ca516968ee6d126c1e829b4b302dd577d28c447d5eaed` | Updated `RULE-IPM-EPOS1755-001` with 16 exceptions; `002` preserved |

### 4.2 Exact Scope Verification
A standalone verification script (`scratch/verify_batch3_diff.py`) compared the updated `draft_rules.json` against the pre-implementation backup:
- **Total rules in backup:** 14
- **Total rules in current:** 14
- **Modified rules:** Exactly 2 rules:
  1. `RULE-IPM-CGSPINALCORDSTIM-001`
  2. `RULE-IPM-EPOS1755-001`
- **Other rules changed:** ZERO. Batch 1 (`RULE-IPM-CGSACROILIAC-001`, `RULE-IPM-CGSACROILIAC-002`, `RULE-IPM-CGEPIDURALPUMPS-001`, `RULE-IPM-CGEPIDURAL-001`), Batch 2 (`RULE-IPM-CGFACETBLOCKS-001`, `RULE-IPM-CGFACETDENERVATION-001`, `RULE-IPM-CGFACETDENERVATION-002`, `RULE-IPM-CGSYMPATHETICBLOCKS-001`), and Advanced Imaging rules were completely untouched.

---

## 5. Test Suite Execution Results

### 5.1 Focused Test Suite: `test_phase8b8d_ipm_batch3_rules.py`
A comprehensive, focused test suite was authored containing 31 test cases validating:
- Positive decision pathways for SCS trial (FBSS, CRPS, DPN, Refractory Angina) and DRGS (lower extremity CRPS).
- MRSA/MSSA colonization screening and boundary timing ($\le 10$ days prior to procedure passes; 11 days fails).
- Full psychological evaluation clearance and 4-element completeness validation.
- Exclusions and contraindications (active infection, cognitive inability, untreated substance abuse, pregnancy).
- EPOS 1755 site-of-care exceptions across major clinical categories (ASA score, BMI, cardiovascular, pulmonary, sleep apnea, pregnancy).
- Dual-track separation between Clinical Necessity and Place of Service.
- Three-valued Kleene indeterminate logic on missing clinical evidence.
- Full CPT candidate routing for `63650` and `63685`.
- Cross-domain isolation between IPM and Advanced Imaging.
- Canonical governance invariants.

```
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_cpt_routing_all_scs_codes PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_cross_domain_isolation PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_dual_track_clinical_met_and_pos_met PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_dual_track_clinical_met_and_pos_not_met_redirection PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_dual_track_clinical_not_met_and_pos_met PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_epos_asa_score_3_qualifies_for_hospital_setting PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_epos_bmi_40_qualifies_for_hospital_setting PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_epos_boundary_asa_score PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_epos_boundary_bmi PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_epos_cardiovascular_comorbidity_qualifies PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_epos_chronic_lung_disease_qualifies PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_epos_indeterminate_missing_evidence PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_epos_pregnancy_qualifies PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_epos_sleep_apnea_qualifies PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_governance_invariants PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_scs_boundary_conservative_therapy_duration PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_scs_boundary_mrsa_decolonization_timing PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_scs_boundary_pain_duration PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_scs_indeterminate_missing_mrsa_status PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_scs_indeterminate_missing_psychological_evaluation PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_scs_negative_active_infection PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_scs_negative_cognitive_inability PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_scs_negative_pregnancy PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_scs_negative_psychological_evaluation_failure PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_scs_pathway_1_crps_positive PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_scs_pathway_1_diabetic_peripheral_neuropathy_positive PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_scs_pathway_1_fbss_positive PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_scs_pathway_1_mrsa_colonized_with_valid_decolonization_plan PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_scs_pathway_1_refractory_angina_positive PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_scs_pathway_2_drgs_lower_limb_crps_positive PASSED
medrule_engine/tests/test_phase8b8d_ipm_batch3_rules.py::TestPhase8B8DIPMBatch3Rules::test_zero_approved_rules_in_db PASSED
============================= 31 passed in 0.59s ==============================
```

### 5.2 Full Repository Regression Test Suite
Executed the entire test suite across all domains and integration layers:
```
pytest -q
........................................................................ [ 18%]
........................................................................ [ 36%]
........................................................................ [ 54%]
............................................................... [ 69%]
........................................................................ [ 87%]
.................................................                        [100%]
400 passed, 9 subtests passed in 30.09s
```
**Regression Summary:** 400 passed out of 400 tests (100% pass rate). Zero test failures, zero regressions across the codebase.

---

## 6. Canonical Governance Invariants Verification

| Invariant | Requirement | Observed State | Compliance Status |
|---|---|---|---|
| **Active Rules Count** | Exactly 128 active rules | 128 loaded in registry | **COMPLIANT** |
| **Approved Rules Count** | Zero approved rules (`APPROVED: 0`) | 0 approved in registry, 0 in DB | **COMPLIANT** |
| **Modified Rules Status** | Both Batch 3 rules must remain in `DRAFT` | Both rules have `extraction_status: "DRAFT"` and `workflow_status: "DRAFT"` | **COMPLIANT** |
| **Canonical Blocked Gates** | All 7 gates must remain blocked | 7 gates strictly blocked | **COMPLIANT** |
| **Clinical / POS Separation** | Dual-track separation preserved | POS track evaluated independently; does not deny clinical necessity | **COMPLIANT** |
| **Three-Valued Evidence Logic** | Missing evidence yields `INSUFFICIENT_INFORMATION` | Evaluated strictly via Kleene 3-valued logic | **COMPLIANT** |

### The 7 Blocked Canonical Gates:
1. `RULE-ADV-PREAMBLE-001`
2. `RULE-ADV-CG2000-003`
3. `RULE-ADV-CG2001-001`
4. `RULE-ADV-CG2066-001`
5. `RULE-ADV-CG2066-002`
6. `RULE-IPM-PREAMBLEIPM-001`
7. `RULE-IPM-CGINFUSIONPUMPS-001`

---

## 7. Policy Ambiguities & Test Limitations

1. **MRSA/MSSA Decolonization Protocol Details:**
   - Guideline 1757 (Physical p. 78) explicitly requires a documented decolonization plan to be performed "no earlier than 10 days prior to the planned procedure" for colonized patients. The policy text does not specify the pharmacological agent (e.g., mupirocin nasal ointment vs. chlorhexidine washes) or culture re-swabbing requirements. The rule faithfully enforces the timing and presence of the documented plan without inventing medication-specific sub-criteria.
2. **EPOS 1755 BMI Threshold Reconciliation:**
   - Physical page 3 of EPOS 1755 explicitly defines morbid obesity qualifying for outpatient hospital care as: BMI $\ge 40.0$ (or BMI $\ge 35.0$ with severe systemic disease). An earlier preliminary draft register note had suggested a threshold of 45. The rule was implemented strictly based on authoritative physical page 3 text ($\text{BMI} \ge 40.0$).
3. **Dual-Track POS Outcomes:**
   - In accordance with project architecture, `RULE-IPM-EPOS1755-001` is tagged with `DecisionTrack.PLACE_OF_SERVICE`. When an authorization case is evaluated, failure to meet hospital outpatient POS criteria produces `place_of_service_outcome: CRITERIA_NOT_MET`, generating an automated redirection notice to an ambulatory surgery center or office, while preserving `clinical_necessity_outcome: CRITERIA_MET`.
4. **Permanent SCS Implantation Rule (`RULE-IPM-CGSPINALCORDSTIM-002`):**
   - As mandated by the phased implementation plan, `RULE-IPM-CGSPINALCORDSTIM-002` remains an un-implemented draft stub reserved for Batch 4. Batch 3 specifically covers trial stimulation (`RULE-IPM-CGSPINALCORDSTIM-001`).

---

## 8. Completion Sign-Off & Next Steps

Phase 8B.8D implementation of Batch 3 is **100% complete**. All requirements and safeguards have been met.

**Execution has halted immediately following Batch 3.** Batch 4 rules (`RULE-IPM-CGSPINALCORDSTIM-002`, `RULE-IPM-CGPERIPHERALNERVE-001`, `RULE-IPM-EPOS1755-002`), clinical approvals, governance approval workflows, and production integrations have not been started.
